- Home
- ASRV vs IMA Comparison
ASRV vs IMA Comparison
Compare ASRV & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASRV | IMA |
|---|---|---|
| Founded | 1983 | 2019 |
| Country | United States | United States |
| Employees | N/A | 17 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.9M | 66.3M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASRV | IMA |
|---|---|---|
| Price | $3.80 | $5.95 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 9.5K | ★ 14.5K |
| Earning Date | 04-21-2026 | 05-15-2026 |
| Dividend Yield | ★ 3.16% | N/A |
| EPS Growth | ★ 61.90 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $14,634,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $34.18 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.64 | $3.94 |
| 52 Week High | $4.04 | $17.50 |
Technical Indicators
Market Signals| Indicator | ASRV | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 48.82 | 57.46 |
| Support Level | $3.62 | $5.70 |
| Resistance Level | $3.93 | $6.06 |
| Average True Range (ATR) | 0.09 | 0.29 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 45.45 | 77.03 |
Price Performance
Historical ComparisonAbout ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.